摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

麦角日亭宁 麦角生物碱 | 511-08-0

中文名称
麦角日亭宁 麦角生物碱
中文别名
麥角克鹼;麦角克碱;麦角日亭宁麦角生物碱;麦角脊亭;爱谷克列斯汀碱
英文名称
ergocristine
英文别名
ergocrystine;Ergocristin;5'-benzyl-12'-hydroxy-2'-isopropyl-ergotamane-18,3',6'-trione;5'α-Benzyl-12'-hydroxy-2'-isopropyl-ergotaman-18,3',6'-trion;5'α-Benzyl-12'-hydroxy-2'-isopropyl-ergotaman-18,3',6'-trion; Ergocristin;(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
麦角日亭宁 麦角生物碱化学式
CAS
511-08-0
化学式
C35H39N5O5
mdl
——
分子量
609.725
InChiKey
HEFIYUQVAZFDEE-MKTPKCENSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    155-157 °C(lit.)
  • 比旋光度:
    D20 -183° (chloroform)
  • 沸点:
    655.69°C (rough estimate)
  • 密度:
    1.1839 (rough estimate)
  • 溶解度:
    可溶于氯仿(少许)、甲醇(少许)
  • 颜色/状态:
    Orthorhombic crystals from benzene
  • 蒸汽压力:
    9.05X10-27 mm Hg at 25 °C 3.44 (est)
  • 旋光度:
    Specific optical rotation: -183 deg at 20 °C/D (chloroform)

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    45
  • 可旋转键数:
    5
  • 环数:
    8.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    118
  • 氢给体数:
    3
  • 氢受体数:
    6

ADMET

毒理性
  • 毒性总结
识别和使用:麦角克辛是一种固体。麦角克辛及其盐类属于第一类化学品。秘密实验室正在使用这种化学物质作为第一类化学品麦角胺和麦角新碱的替代品,非法制造被列为一类受控物质的麦角酸二乙基酰胺(LSD)。人体研究:在所有测试的麦角生物碱中,麦角克辛是最具细胞毒性的化合物,能从1微摩尔浓度开始诱导人肾细胞凋亡。动物研究:从挪威西南部采集的麦田草中的麦角被检查出生物碱并口服给四只大约10个月大的羊。以每天每千克体重0.12-0.75克的速度给硬壳药,持续4-27天。硬壳药中总生物碱的浓度估计约为0.4%。通过薄层色谱法鉴定出麦角辛、麦角克辛、麦角胺及其三种相应的异构体。在总生物碱中,麦角辛和麦角克辛各占35%,麦角胺占15%,异构体各占5%。在寒冷潮湿的天气中,三只在外喂养的羊都生病了,表现出食欲不振和脉搏率增加。在室内喂养的那只羊没有出现症状,也没有尸检病变。对三只表现出症状的羊进行尸检时,在消化道,尤其是瘤胃和盲肠中,发现了粘膜充血、出血、糜烂和坏死。其中两只羊的一些肢体和尾巴远端发现了轻微水肿,但没有观察到坏疽的迹象。五种麦角生物碱,即d-麦角酸衍生物,在培养的中国仓鼠卵巢细胞中测试了诱导姐妹染色单体交换(SCE)频率的能力。测试物质的浓度在10(-5)到10(-8) M之间。麦角胺、麦角新碱和甲基麦角新碱在所有使用的浓度下都显著增加了SCE的数量,而麦角克辛只有在最高浓度下才会出现这种情况。由于麦角克辛引起的血管收缩是通过α2-肾上腺素受体介导的,在大鼠中,麦角克辛作为α2-肾上腺素受体的激动剂,以及α1-肾上腺素受体的拮抗剂。
IDENTIFICATION AND USE: Ergocristine is a solid. Ergocristine and its salts are List I Chemicals. Clandestine laboratories are using this chemical as a substitute for the List I chemicals ergotamine and ergonovine to illicitly manufacture the schedule I controlled substance lysergic acid diethylamide (LSD). HUMAN STUDIES: Of all tested ergot alkaloids, ergocristine was the most cytotoxic compound inducing apoptosis in human kidney cells starting at a concentration of 1uM. ANIMAL STUDIES: A sample of ergot from meadow grass collected in the south-western part of Norway was examined for alkaloids and dosed orally to four lambs about 10 months old. Sclerotia were dosed at a rate of 0.12-0.75 g per kg body weight per day for 4-27 days. The concentration of total alkaloids in the sclerotia was estimated to be about 0.4%. Ergosine, ergocristine, ergotamine and the three corresponding isomers were identified by thin-layer chromatography. Of the total alkaloids, ergosine and ergocristine constituted 35% each, ergotamine 15% and the isomers 5% each. Three lambs dosed outdoors in cold and wet weather all became ill, with anorexia and increased pulse rate. No symptoms nor post mortem lesions were seen in the single lamb kept indoors. On post mortem examination of the three lambs showing symptoms, hyperemic mucosae, hemorrhages, erosions and necroses in the digestive tract, most pronounced in abomasum and cecum, were demonstrated. In two lambs, slight edema was found distally in some of the limbs and tail, but no sign of gangrene was observed. Five ergot alkaloids, d-lysergic acid derivatives, were tested for the induction of sister chromatid exchange (SCE) frequencies in cultured Chinese hamster ovary cells. The concentrations of the test substances ranged between 10(-5) and 10(-8) M. Ergotamine, ergonovine, and methylergonovine induced a significantly high number of SCEs at all the concentrations used, while with ergocristine this occurred only at the highest concentration. Vasoconstriction due to ergocristine is mediated by alpha 2-adrenoceptors and in the rat, ergocristine acts as an alpha 2-adrenoceptors agonist, and an alpha 1-adrenoceptors antagonist.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 毒性总结
麦角生物碱倾向于作为一个整体发挥作用,在肾上腺素能、多巴胺能和血清素能受体上产生复杂且多变的部分激动或拮抗作用。与这些效果相关的变量受到药剂、剂量、物种、组织、生理和内分泌状态以及实验条件的影响。特别是,麦角生物碱已被证明对5-HT1和5-HT2血清素受体、D1和D2多巴胺受体以及α-肾上腺素受体具有显著的亲和力。这可能导致多种不同的效果,包括血管收缩、抽搐和幻觉。麦角新碱也被知道具有非受体特异性的催产素活性。(A2914, A2915, A2916)
Ergoline alkaloids tend to act as a group, producing complex and variable effects of partial agonism or antagonism at adrenergic, dopaminergic, and serotonergic receptors. Variables relating to these effects are influenced by the agent, dosage, species, tissue, physiological, and endocrinological state, and experimental conditions. In particular, ergoline alkaloids have been shown to have the significant affinity towards the 5-HT1 and 5-HT2 serotonin receptors, D1 and D2 dopamine receptors, and alpha-adrenergic receptors. This can result in a number of different effects, including vasoconstriction, convulsions, and hallucinations. Ergometrine is also known to have a non-receptor specific oxytocic activity. (A2914, A2915, A2916)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌物分类
对人类不具有致癌性(未被国际癌症研究机构IARC列名)。
No indication of carcinogenicity to humans (not listed by IARC).
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 健康影响
摄入麦角生物碱已知会导致麦角中毒。麦角中毒分为两种形式,坏疽型和惊厥型,可能取决于存在的麦角生物碱的不同种类和数量。
Ingestion of ergoline alkaloids is known to cause the disease ergotism. Ergotism occurs in two forms, gangrenous and convulsive, likely depending on the different kinds and amounts of ergoline alkaloids present. (A2913)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 暴露途径
口服、皮肤、吸入和 parenteral(被污染的药物)。 (A3101)
Oral, dermal, inhalation, and parenteral (contaminated drugs). (A3101)
来源:Toxin and Toxin Target Database (T3DB)

安全信息

  • 危险等级:
    6.1(b)
  • 危险品标志:
    T
  • 危险类别码:
    R23/24/25
  • 危险品运输编号:
    UN 1544
  • RTECS号:
    KE1180000
  • 包装等级:
    III
  • 危险类别:
    6.1(b)
  • 安全说明:
    S22,S36/37/39,S45

SDS

SDS:b3fb9a54fd236ab05cb037221f6d4424
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SPIROLACTAM CGRP RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DE RÉCEPTEUR DE CGRP À BASE DE SPIROLACTAME
    申请人:MERCK SHARP & DOHME
    公开号:WO2013169567A1
    公开(公告)日:2013-11-14
    The present invention is directed to spirolactam analogues which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    本发明涉及螺内酰胺类似物,其为CGRP受体拮抗剂,可用于治疗或预防涉及CGRP的疾病,如偏头痛。该发明还涉及包含这些化合物的药物组合物,以及在预防或治疗涉及CGRP的这类疾病中使用这些化合物和组合物。
  • [EN] IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS D'IMIDAZOLINONE EN TANT QU'ANTAGONISTES DE RÉCEPTEURS CGRP
    申请人:MERCK SHARP & DOHME
    公开号:WO2010077752A1
    公开(公告)日:2010-07-08
    The present invention is directed to imidazolinone derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    本发明涉及嘧啶啉酮衍生物,其为CGRP受体拮抗剂,可用于治疗或预防涉及CGRP的疾病,如偏头痛。该发明还涉及包含这些化合物的药物组合物,以及在预防或治疗涉及CGRP的这类疾病中使用这些化合物和组合物。
  • PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS
    申请人:Bell Ian M.
    公开号:US20120122899A1
    公开(公告)日:2012-05-17
    The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    本发明涉及哌啶酮羧酰胺吖啶衍生物,它们是CGRP受体拮抗剂,可用于治疗或预防CGRP参与的疾病,如偏头痛。该发明还涉及包含这些化合物的药物组合物,以及在预防或治疗CGRP参与的这类疾病中使用这些化合物和组合物。
  • 2,3-Dihydro-2-oxoergolene Derivatives
    作者:Ladislav Cvak、Josef Stuchlík、Magdalena Schreiberová、Petr Sedmera、Vladimír Havlíček、Miroslav Flieger
    DOI:10.1135/cccc19940929
    日期:——

    A general procedure for the preparation of 2-oxo derivatives of 8- or 9-ergolene is reported. Mass and NMR spectra of these compounds are discussed.

    一种制备8-或9-麦角甾烯的2-酮衍生物的一般程序已报道。讨论了这些化合物的质谱和核磁共振谱。
  • Process for the preparation of 2-halogenated ergoline derivatives
    申请人:Richter Gedeon Vegyeszeti Gyar Rt.
    公开号:US04816587A1
    公开(公告)日:1989-03-28
    The invention relates to a novel process for the halogenation in 2-position of ergot alkaloids. The process is characterized by that as a halogenating agent a system consisting of dimethylsulfoxide, a trialkylhalosilane or triarylhalosilane and optionally a hydrogen halide is used.
    这项发明涉及一种新颖的麦角生物碱2位卤代化过程。该过程的特点是使用二甲基亚砜、三烷基卤硅烷或三芳基卤硅烷以及可选的氢卤作为卤代试剂的体系。
查看更多